FDA Approves DEXTROSE AND SODIUM CHLORIDE — B. Braun Medical Inc.

B. Braun Medical Inc.'s long-standing legacy continues as the New Drug Application for Dextrose and Sodium Chloride remains fully active, reinforcing the company's dominant position in the critical intravenous solutions market. The permanent approval underscores the enduring commercial reliance on this essential fluid product and supports B. Braun’s steady revenue stream within hospital infrastructure.